11-5225668-G-T
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM5PP3_Strong
The NM_000518.5(HBB):c.374C>A(p.Pro125Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000753 in 1,461,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P125R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Publications
- dominant beta-thalassemiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
- hemoglobin M diseaseInheritance: AD Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen
- beta thalassemiaInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- beta-thalassemia HBB/LCRBInheritance: AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
- sickle cell disease and related diseasesInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- erythrocytosis, familial, 6Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Heinz body anemiaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- sickle cell diseaseInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary persistence of fetal hemoglobin-beta-thalassemia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- beta-thalassemia intermediaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- beta-thalassemia majorInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- delta-beta-thalassemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin C diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin C-beta-thalassemia syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin E diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin E-beta-thalassemia syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary persistence of fetal hemoglobin-sickle cell disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-beta-thalassemia disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-hemoglobin c disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-hemoglobin d disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-hemoglobin E disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461666Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727174 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Erythrocytosis, familial, 6 Pathogenic:1
- -
not provided Uncertain:1
It has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). In the published literature, the variant has been reported in an individual with erythrocytosis and in an individual with normal hematologic findings whose Hb F was high (4.7%) and Hb A2 was normal (2.8%) (PMID: 31388287 (2019)). Functional studies have shown that the Hb Ty Gard variant has a normal Hb Bohr effect, normal cooperativity, increased oxygen affinity, and is relatively stable (PMID: 639985 (1978)). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -
HEMOGLOBIN TY GARD Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at